Matthias K Werner1, Holger Schmidt, Nina F Schwenzer. 1. Department of Radiology, Diagnostic and Interventional Radiology, Eberhard-Karls-University Tübingen, Hoppe-Seyler-St 3, 72076 Tübingen, Germany.
Abstract
OBJECTIVE: This article provides a short overview of hybrid imaging and the potential advantages of combined MR/PET. We will address some of the challenges that had to be met before MR/PET could become clinically available as well as further scientific work that has to be done to increase the potential benefit of this emerging hybrid modality. CONCLUSION: Hybrid imaging, the combination of two imaging modalities into one, promises the compensation of specific deficits of the modalities involved. PET/CT has gained wide acceptance for oncologic imaging in recent years; however, MRI has certain advantages that could make combined MR/PET more tempting in various clinical applications. The development of new clinical whole-body MR/PET systems offers new insights in metabolic and functional processes in oncology as well as cardiovascular and neurologic diseases.
OBJECTIVE: This article provides a short overview of hybrid imaging and the potential advantages of combined MR/PET. We will address some of the challenges that had to be met before MR/PET could become clinically available as well as further scientific work that has to be done to increase the potential benefit of this emerging hybrid modality. CONCLUSION: Hybrid imaging, the combination of two imaging modalities into one, promises the compensation of specific deficits of the modalities involved. PET/CT has gained wide acceptance for oncologic imaging in recent years; however, MRI has certain advantages that could make combined MR/PET more tempting in various clinical applications. The development of new clinical whole-body MR/PET systems offers new insights in metabolic and functional processes in oncology as well as cardiovascular and neurologic diseases.
Authors: Sasan Partovi; Andres A Kohan; Lisa Zipp; Peter Faulhaber; Christos Kosmas; Pablo R Ros; Mark R Robbin Journal: Int J Clin Exp Med Date: 2014-03-15
Authors: Kerstin Zwirner; Daniela Thorwarth; René M Winter; Stefan Welz; Jakob Weiss; Nina F Schwenzer; Holger Schmidt; Christian la Fougère; Konstantin Nikolaou; Daniel Zips; Sergios Gatidis Journal: Strahlenther Onkol Date: 2018-03-21 Impact factor: 3.621
Authors: Sasan Partovi; Andres Kohan; Chiara Gaeta; Christian Rubbert; Jose L Vercher-Conejero; Robert S Jones; James K O'Donnell; Patrick Wojtylak; Peter Faulhaber Journal: Am J Nucl Med Mol Imaging Date: 2013-04-09
Authors: Valeria Romeo; Alfredo Esposito; Simone Maurea; Luigi Camera; Pier Paolo Mainenti; Giovannella Palmieri; Carlo Buonerba; Marco Salvatore Journal: Pol J Radiol Date: 2015-01-13
Authors: Miguel Ramalho; Mamdoh AlObaidy; Onofrio A Catalano; Alexander R Guimaraes; Marco Salvatore; Richard C Semelka Journal: Eur J Radiol Open Date: 2014-09-16